(
out of
82
reviews
)
Clinical Locations
Primary Location
Huntsman Cancer Institute - Cancer Hospital South
Radiation Oncology
1950 Circle of Hope
Salt Lake City
,
UT
84112
Sugar House Health Center
1280 E. Stringham Avenue
Salt Lake City
,
UT
84106
Board Certification
|
American Board of Radiology (Radiation Oncology)
|
Patient Rating
Patients consistently report that Dr. Lloyd is personable, compassionate, and takes time to listen and answer questions, explaining treatment options clearly and instilling confidence. Many comments praise his clinical expertise and the coordinated, supportive care from his team during radiation and follow-up, noting responsiveness by email and continuity of care. One reviewer mentioned a routine return visit involved little discussion beyond advising a yearly follow-up, but overall feedback is overwhelmingly positive and patients frequently recommend him.
Generated via Patient Reviews
5.0
/5
( out of
82 reviews
)
The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers. The scale on which responses are measured is 1 to 5 with 5 being the best score.
Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.
Board Certification and Academic Information
| Academic Departments |
Radiation Oncology
-Professor |
|---|---|
| Board Certification |
American Board of Radiology (Radiation Oncology)
|
Education history
| Undergraduate | Economics and Zoology - Brigham Young University | B.A. |
|---|---|---|
| Graduate Training | Yale School of Medicine | M.H.S. |
| Professional Medical | Medicine - Yale School of Medicine | M.D. |
| Research Fellow | Yale School of Medicine | Research Fellow |
| Internship | Internal Medicine - University of Utah Affiliated Hospitals | Intern |
| Residency | Radiation Oncology - Yale-New Haven Hospital | Resident |
Selected Publications
Journal Article
- Hu S, Chang CP, Gill D, Deshmukh V, Newman M, Date A, Sanchez A, Lloyd S, O'Neil B, Hashibe (2026). Cardiovascular Disease in a Population-Based Cohort of Prostate Cancer Patients With Long-Term Follow-Up. Clinical genitourinary cancer, 24(4), 102553.
- Galarza Fortuna GM, Grass D, Maughan BL, Jain RK, Dechet C, Beck J, Schuetz E, Sanchez A, O'Neil B, Poch M, Li R, Lloyd S, Tward J, Phunrab T, Hawks JL, Swami U, Boucher KM, Agarwal N, Gupta (2025). Nivolumab adjuvant to chemo-radiation in localized muscle-invasive urothelial cancer: primary analysis of a multicenter, single-arm, phase II, investigator-initiated trial (NEXT). Journal for immunotherapy of cancer, 13(3),
- Howell JN, Mark B, Wada DA, Bowling M, Wei M, Lloyd SL, Gaffney DK, Maity A, LaRiviere MJ, Rule WG, Grant JD, Deshmukh V, Newman M, Date A, Hashibe M, Tao (2025). Mental Health Diagnoses in Patients With Mycosis Fungoides and Potential Impact on Oncologic Outcomes. Cancer medicine, 14(5), e70577.
- Tward J, Lloyd S, Johnson S, Dechet C, Nei BO, Maughan B, Swami U, Gupta S, Sanchez A, Kokeny K, Agarwal (2025). A Phase 2 Trial of Radium(223) and Stereotactic Ablative Radiation Therapy in Hormone-Naïve Men with Oligometastatic Prostate Cancer to Bone: The RadSABR Study. International journal of radiation oncology, biology, physics,
- Kabarriti R*, Lloyd S* (co-first author), Jabalee J, Del Vecchio Fitz C, Tao R, Slater T, Jacobs C, Inocencio S, Rutenberg M, Matthiesen C, Neff K, Liu GF, Juarez TM, Liauw S (2025). Evaluating Tumor Tissue Modified Viral (TTMV)-HPV DNA for the Early Detection of Anal Squamous Cell Carcinoma Recurrence. Cancers, 17(2),
- Liu K, Chang CE, Lloyd S, Tao R, Nguyen T, Zhang ZF, Hashibe (2025). The risk of type 2 diabetes among older Asian, Native Hawaiian and Pacific Islander colorectal cancer survivors:a population-based study using SEER-Medicare database. Cancer epidemiology, biomarkers & prevention,
- Feigenberg SJ, Costabile F, Tanes C, Bittinger K, O'Connor R, Agarwal D, Skoufos G, Salaris S, Hatzigeorgiou A, Kostopoulos N, Lloyd S, Friedes C, Chen L, Yegya-Raman N, Cengel K, Levin W, Valenti¿ B, Quarton T, Shestov AA, Berman A, Bradley J, Maity A, Koumenis C, Ben-Josef E, Facciabene (2025). Enhancing outcomes in medically inoperable early-stage NSCLC with gut-targeted antibiotics and stereotactic body radiotherapy: results from a randomized pilot study. Journal for immunotherapy of cancer, 13(7),
- Paccione EN, Kwan E, Bergquist JA, Shah AS, Orkild BA, Hunt B, Salter ML, Mendes J, DiBella E, Arai AE, Bunch TJ, MacLeod RS, Kunz JN, Hitchcock Y, Kokeny KE, Lloyd S, Ranjan (2025). Radiation induces diffuse extracellular remodeling of healthy myocardium in a dose- and time-dependent manner without a dense ablative effect. Heart rhythm,
- Urias E, Lee J, Weil CR, Roach E, Lloyd S, Hashibe M, Facciabene A, Maity A, Tao (2025). Combined immune checkpoint inhibitors and ablative radiotherapy in metastatic cancers: a meta-analysis of prospective clinical trials. BMJ oncology, 4(1), e000732.
- Chang Esther CP, Huang D, Lloyd S, Henry NL, O'Neil B, Hashibe (2025). Risks of adverse health outcomes among older rural prostate cancer survivors in the SEER-Medicare data. The Journal of rural health, 41(2), e70029.
- Anker CJ, Arshad J, Cellini F, Dehal A, Dolan J, Gillett SR, Haddock MG, Haustermans K, Hong TS, Howell KJ, Jabbour SK, Kitano M, Lin C, Lloyd S, Peterson J, Roeder F, Smith GL, Stewart J, Tchelebi LT, Bradfield L, Willett C (2025). Radiation Therapy for Gastric Cancer: An ASTRO Clinical Practice Guideline. Practical radiation oncology,
- Kabarriti R, Lloyd S, Jabalee J, Gay LM, Slater T, Guzman K, Jacobs C, Inocencio S, Lin R, Nguyen C, MacEwan I, Crawford AH, Rutenberg M, Singh J, Ross J, Kim-Wang S, Matthiesen C, Neff K, Liu GF, Juarez TM, Liauw S (2025). Resolving Clinically Indeterminate Findings During Anal Cancer Surveillance with TTMV-HPV DNA. Cancers, 18(1),
- Kachnic LA, Winter K, Suntharalingam M, Ilson D, Konski A, Lloyd S, McAvoy SA, Lad T, Olowokure OG, Samson P, Gore EM, Meyer JE, Videtic GMM, Clump DA, Raben A, Kayaleh O, Barker J Jr, Haddock MG, Hopkins JO, Bruner D (2024). Patient-reported outcomes (PROs) in NRG Oncology RTOG 0436: a phase III trial evaluating the addition of cetuximab to paclitaxel, cisplatin, and radiation for esophageal cancer treated without surgery. Quality of life research,
- Koric A, Chang CE, Lloyd S, Dodson M, Deshmukh VG, Newman MG, Date AP, Doherty JA, Gren LH, Porucznik CA, Haaland BA, Henry NL, Hashibe (2024). Capturing Chemotherapy and Radiotherapy Dose Among Breast Cancer Patients With the Utah All-Payer Claims Database Compared With Gold-Standard Abstraction. Cancer medicine, 13(22), e70411.
- Hallemeier CL, Moughan J, Haddock MG, Herskovic AM, Minsky BD, Suntharalingam M, Zeitzer KL, Garg MK, Greenwald BD, Komaki RU, Puckett LL, Kim H, Lloyd S, Bush DA, Kim HE, Lad TE, Meyer JE, Okawara GS, Raben A, Schefter TE, Barker JL Jr, Falkson CI, Videtic GMM, Jacob R, Winter KA, Crane C (2023). Association of Radiotherapy Duration With Clinical Outcomes in Patients With Esophageal Cancer Treated in NRG Oncology Trials: A Secondary Analysis of NRG Oncology Randomized Clinical Trials. JAMA network open, 6(4), e238504.
- Huang D, Chang CE, Newman M, Deshmukh V, Snyder J, Date A, Galvao C, Lloyd S, Henry NL, O'Neil B, Hashibe (2023). Adverse health outcomes among rural prostate cancer survivors: A population-based study. Cancer epidemiology, 86, 102430.
- Koric A, Mark B, Chang CP, Lloyd S, Dodson M, Deshmukh VG, Newman M, Date A, Gren LH, Porucznik CA, Haaland B, Henry NL, Hashibe (2023). Adverse Health Outcomes Among Rural And Urban Breast Cancer Survivors: A Population-Based Cohort Study. Cancer epidemiology, biomarkers & prevention, 86(102430), 1302-1311.
- Nielsen S, O'Neil B, Chang CP, Mark B, Snyder J, Deshmukh V, Newman M, Date A, Galvao C, Henry NL, Lloyd S, Hashibe (2023). Determining the association of rurality and cardiovascular disease among prostate cancer survivors. Urologic oncology, 41(10), 429.e15-429.e23.
- Price RG, Lloyd S, Wang X, Haaland B, Nelson G, Salter (2023). Adipose Tissue Distribution and Body Mass Index (BMI) Correlation With Daily Image-Guided Radiotherapy (IGRT) Shifts of Abdominal Radiation Therapy Patients. Cureus, 15(6), e40979.
- Hu S, Chang CP, Snyder J, Deshmukh V, Newman M, Date A, Galvao C, Haaland B, Porucznik CA, Gren LH, Sanchez A, Lloyd S, O'Neil B, Hashibe (2023). Mental health outcomes in a population-based cohort of patients with prostate cancer. Journal of the National Cancer Institute, 116(3), 445-454.
- Hu S, Chang CP, Snyder J, Deshmukh V, Newman M, Date A, Galvao C, Porucznik CA, Gren LH, Sanchez A, Lloyd S, Haaland B, O'Neil B, Hashibe (2023). Comparing Active Surveillance and Watchful Waiting With Radical Treatment Using Machine Learning Models Among Patients With Prostate Cancer. JCO clinical cancer informatics, 7, e2300083.
- Fenlon JB, Hutten RJ, Weil CR, Lloyd S, Cannon DM, Kerrigan K, Cannon RB, Hitchcock Y (2022). Comparing adjuvant radiation to adjuvant chemoradiation in postsurgical p16+ oropharyngeal carcinoma patients with extranodal extension or positive margins. Head & neck, 44(3), 606-614.
- Parsons MW, Hutten RJ, Tward A, Khouri A, Peterson J, Morrell G, Lloyd S, Cannon DM, Johnson S (2022). The Effect of Maximum Tumor Diameter by MRI on Disease Control in Intermediate and High-risk Prostate Cancer Patients Treated With Brachytherapy Boost. Clinical genitourinary cancer, 20(1), e68-e74.
- Parsons M, Lloyd S, Johnson S, Scaife C, Soares H, Kim R, Kim R, Garrido-Laguna I, Tao (2022). The Implications of Treatment Delays in Adjuvant Therapy for Resected Cholangiocarcinoma Patients. Journal of gastrointestinal cancer, 54(2), 492-500.
- Hutten RJ, Weil CR, Gaffney DK, Kokeny K, Lloyd S, Rogers CR, Suneja (2022). Worsening Racial Disparities in Utilization of Intensity Modulated Radiation Therapy. Advances in radiation oncology, 7(3), 100887.
- Tao R, Chen Y, Kim S, Ocier K, Lloyd S, Poppe MM, Lee CJ, Glenn MJ, Smith KR, Fraser A, Deshmukh V, Newman MG, Snyder J, Rowe KG, Gaffney DK, Haaland B, Hashibe (2022). Mental health disorders are more common in patients with Hodgkin lymphoma and may negatively impact overall survival. Cancer, 128(19), 3464-3572.
- Rock CB, Hutten RJ, Weil CR, Lloyd S, Kerrigan KC, Cannon RB, Hitchcock Y (2022). Survival outcomes for patients with T3N0M0 squamous cell carcinoma of the glottis treated with definitive radiation alone versus chemoradiation. Head & neck, 45(2), 431-438.
- Hutten R, Khouri A, Parsons M, Tward A, Wilson T, Peterson J, Morrell G, Dechet C, O'Neil B, Schmidt B, Kokeny K, Lloyd S, Cannon D, Tward J, Sanchez A, Johnson (2022). The Clinical Significance of Maximum Tumor Diameter on MRI in Men Undergoing Radical Prostatectomy or Definitive Radiotherapy for Locoregional Prostate Cancer. Clinical genitourinary cancer, 20(6), e453-e459.
- Hutten RJ, Weil CR, Gaffney DK, Kokeny K, Lloyd S, Rogers CR, Suneja (2022). Racial and Ethnic Health Disparities in Delay to Initiation of Intensity-Modulated Radiotherapy. JCO oncology practice, 18(10), e1694-e1703.
- Mao YS, Gao SG, Li Y, Hao AL, Liu JF, Li XF, Rong TH, Fu JH, Ma JQ, Xu MQ, Zhang RQ, Xiao GM, Fu XN, Chen KN, Mao WM, Liu YY, Liu HX, Zhang ZR, Fang Y, Fu DH, Wei XD, Yuan LG, Muhammad S, Wei WQ, Chiu PW, Lloyd S, Schlottmann F, Meredith K, Pimiento JM, Gao YB, He (2022). Efficacy and safety of esophagectomy via left thoracic approach versus via right thoracic approach for middle and lower thoracic esophageal cancer: a multicenter randomized clinical trial (NST1501). Annals of translational medicine, 10(16), 904.
- Hutten RJ, Parsons MW, Weil CR, Tward JD, Lloyd S, Sanchez A, Lester-Coll N, Johnson S (2021). Temporal Trends and Predictors in Diagnosing Pathologic Node-Positive Prostate Cancer in Clinically Node-Negative Patients. Clinical genitourinary cancer, 19(6), e360-e366.
- Odell DW, Albrechtsen RD, Sindt JE, Gole R, Brown S, Parsons MW, Paxton AB, Sarkar V, Lloyd S, Brogan SE, Tao (2021). The Effect of Measured Radiotherapy Dose on Intrathecal Drug Delivery System Function. Neuromodulation, 24(7), 1204-1208.
- Parsons M, Lloyd S, Johnson S, Scaife C, Varghese T, Glasgow R, Garrido-Laguna I, Tao (2021). Refusal of Local Therapy in Esophageal Cancer and Impact on Overall Survival. Annals of surgical oncology, 28(2), 663-675.
- Hutten RJ, Weil CR, Tward JD, Lloyd S, Johnson S (2021). Patterns of Care and Treatment Outcomes in Locoregional Squamous Cell Carcinoma of the Prostate. European urology open science, 23, 30-33.
- Sarkar V, Lloyd S, Paxton A, Dial C, Rassiah P, Szegedi MW, Hitchcock YJ, Salter B (2021). Evaluation of the dosimetric impact of changes in shoulder position on target coverage for spine SBRT to metastases in the lower cervical spine region. Journal of radiosurgery and SBRT, 7(4), 321-328.
- Szegedi M, Boehm C, Paxton A, Rassiah-Szegedi P, Sarkar V, Zhao H, Su F, Kokeny KE, Lloyd S, Tward J, Salter B (2020). Comparison of transperineal ultrasound image guidance technique to transabdominal technique for prostate radiation therapy. Medical physics, 47(12), 6113-6121.
- Tward JD, O'Neil B, Boucher K, Kokeny K, Lowrance WT, Lloyd S, Cannon D, Stephenson RA, Agarwal N, Farr T, Petragallo R, Sherar NZ, Kunz I, Hofer A, Courdy S, Shrieve DC, Dechet (2020). Metastasis, Mortality, and Quality of Life for Men With NCCN High and Very High Risk Localized Prostate Cancer After Surgical and/or Combined Modality Radiotherapy. Clinical genitourinary cancer, 18(4), 274-283.e5.
- Wells SM, Boothe D, Ager BJ, Tao R, Gilcrease GW 3rd, Lloyd (2020). Analysis of Nonsurgical Treatment Options for Metastatic Rectal Cancer. Clinical colorectal cancer, 19(2), 91-99.e1.
- Aylward A, Park J, Abdelaziz S, Hunt JP, Buchmann LO, Cannon RB, Rowe K, Snyder J, Deshmukh V, Newman M, Wan Y, Fraser A, Smith K, Lloyd S, Hitchcock Y, Hashibe M, Monroe M (2020). Individualized prediction of late-onset dysphagia in head and neck cancer survivors. Head & neck, 42(4), 708-718.
- Gruhl JD, Garrido-Laguna I, Francis SR, Affolter K, Tao R, Lloyd (2020). The impact of squamous cell carcinoma histology on outcomes in nonmetastatic pancreatic cancer. Cancer medicine, 9(5), 1703-1711.
- Cannon RB, Kull AJ, Carpenter PS, Francis S, Buchmann LO, Monroe MM, Lloyd S, Hitchcock YJ, Cannon D, Weis JR, Houlton JJ, Hunt J (2019). Adjuvant radiation for positive margins in adult head and neck sarcomas is associated with improved survival: Analysis of the National Cancer Database. Head & neck, 41(6), 1873-1879.
- Aylward A, Abdelaziz S, Hunt JP, Buchmann LO, Cannon RB, Lloyd S, Hitchcock Y, Hashibe M, Monroe M (2019). Rates of Dysphagia-Related Diagnoses in Long-Term Survivors of Head and Neck Cancers. Otolaryngology--head and neck surgery, 161(4), 643-651.
- An Y, Jiang W, Andraos TY, Reddy JP, Yehia ZA, Lloyd S, Duvic M, D'Souza NM, Milgrom SA, Pinnix CC, Oki Y, Smith GL, Wilson LD, Dabaja B (2019). Multi-institutional Investigation: Circulating CD4:CD8 ratio is a prognosticator of response to total skin electron beam radiation in mycosis fungoides. Radiotherapy and oncology, 131, 88-92.
- Swords DS, Francis SR, Lloyd S, Garrido-Laguna I, Mulvihill SJ, Gruhl JD, Christensen MC, Stoddard GJ, Firpo MA, Scaife C (2019). Lymph Node Ratio in Pancreatic Adenocarcinoma After Preoperative Chemotherapy vs. Preoperative Chemoradiation and Its Utility in Decisions About Postoperative Chemotherapy. Journal of gastrointestinal surgery, 23(7), 1401-1413.
- Coffman A, Torgeson A, Lloyd (2019). Correlates of Refusal of Surgery in the Treatment of Non-metastatic Pancreatic Adenocarcinoma. Annals of surgical oncology, 26(1), 98-108.
- Torrecillas V, Shepherd HM, Francis S, Buchmann LO, Monroe MM, Lloyd S, Cannon D, Hitchcock YJ, Weis JR, Hunt JP, Houlton JJ, Cannon R (2018). Adjuvant radiation for T1-2N1 oral cavity cancer survival outcomes and utilization treatment trends: Analysis of the SEER database. Oral oncology, 85, 1-7.
- Tao R, Ager B, Lloyd S, Torgeson A, Denney M, Gaffney D, Kharofa J, Lin SH, Koong AC, Anzai Y, Hoffman J (2018). Hypoxia imaging in upper gastrointestinal tumors and application to radiation therapy. Journal of gastrointestinal oncology, 9(6), 1044-1053.
- Gajiwala S, Torgeson A, Garrido-Laguna I, Kinsey C, Lloyd (2018). Combination immunotherapy and radiation therapy strategies for pancreatic cancer-targeting multiple steps in the cancer immunity cycle. Journal of gastrointestinal oncology, 9(6), 1014-1026.
- Sarkar V, Lloyd S, Paxton A, Huang L, Su FC, Tao R, Tward J, Zhao H, Salter (2018). Daily breathing inconsistency in pancreas SBRT: a 4DCT study. Journal of gastrointestinal oncology, 9(6), 989-995.
- Mancini BR, Stein S, Lloyd S, Rutter CE, James E, Chang BW, Lacy J, Johung K (2018). Chemoradiation after FOLFIRINOX for borderline resectable or locally advanced pancreatic cancer. Journal of gastrointestinal oncology, 9(6), 982-988.
- Orton A, Boothe D, Evans D, Lloyd S, Monroe MM, Jensen R, Shrieve DC, Hitchcock Y (2018). Esthesioneuroblastoma: A Patterns-of-Care and Outcomes Analysis of the National Cancer Database. Neurosurgery, 83(5), 940-947.
- Nevala-Plagemann C, Francis S, Cavalieri C, Tao R, Whisenant J, Glasgow R, Scaife C, Lloyd S, Garrido-Laguna (2018). Benefit of adjuvant chemotherapy based on lymph node involvement for oesophageal cancer following trimodality therapy. ESMO open, 3(5), e000386.
- Torgeson A, Garrido-Laguna I, Tao R, Cannon GM, Scaife CL, Lloyd (2018). Value of surgical resection and timing of therapy in patients with pancreatic cancer at high risk for positive margins. ESMO open, 3(1), e000282.
- McLaughlin PW, Liss AL, Nguyen PL, Assimos DG, D'Amico AV, Gottschalk AR, Gustafson GS, Keole SR, Liauw SL, Lloyd S, Movsas B, Prestidge BR, Showalter TN, Taira AV, Vapiwala N, Davis BJ (2017). ACR Appropriateness Criteria(R) Locally Advanced, High-Risk Prostate Cancer. Am J Clin Oncol, 40(1), 1-10.
- Cannon RB, Sowder JC, Buchmann LO, Hunt JP, Hitchcock YJ, Lloyd S, Grossman KF, Monroe M (2017). Increasing use of nonsurgical therapy in advanced-stage oral cavity cancer: A population-based study. Head & neck, 39(1), 82-91.
- Sowder JC, Cannon RB, Buchmann LO, Hunt JP, Hitchcock Y, Lloyd S, Grossmann KF, Monroe M (2017). Treatment-related determinants of survival in early-stage (T1-2N0M0) oral cavity cancer: A population-based study. Head & neck, 39(5), 876-880.
- Lloyd S, Alektiar KM, Nag S, Huang YJ, Deufel CL, Mourtada F, Gaffney D (2017). Intraoperative high-dose-rate brachytherapy: An American Brachytherapy Society consensus report. Brachytherapy, 16(3), 446-465.
- Gan M, Boothe D, Neklason DW, Samadder NJ, Frandsen J, Keener MB, Lloyd (2017). Outcomes and complications of radiation therapy in patients with familial adenomatous polyposis. Journal of gastrointestinal oncology, 8(4), 643-649.
- Zaorsky NG, Showalter TN, Ezzell GA, Nguyen PL, Assimos DG, D'Amico AV, Gottschalk AR, Gustafson GS, Keole SR, Liauw SL, Lloyd S, McLaughlin PW, Movsas B, Prestidge BR, Taira AV, Vapiwala N, Davis B (2017). ACR Appropriateness Criteria® External Beam Radiation Therapy Treatment Planning for Clinically Localized Prostate Cancer, Part II of II. Advances in radiation oncology, 2(3), 437-54.
- Monroe MM, Buchmann LO, Hunt JP, Hitchcock YJ, Lloyd S, Hashibe (2017). The Benefit of Adjuvant Radiation in Surgically-Treated T1-2 N1 Oropharyngeal Squamous Cell Carcinoma. Laryngoscope investigative otolaryngology, 2(2), 57-62.
- Torgeson A, Lloyd S, Boothe D, Cannon G, Garrido-Laguna I, Whisenant J, Lewis M, Kim R, Scaife C, Tao (2017). Chemoradiation Therapy for Unresected Extrahepatic Cholangiocarcinoma: A Propensity Score-Matched Analysis. Annals of surgical oncology, 24(13), 4001-4008.
- Francis SR, Orton A, Thorpe C, Stoddard G, Lloyd S, Anker C (2017). Toxicity and Outcomes in Patients With and Without Esophageal Stents in Locally Advanced Esophageal Cancer. International journal of radiation oncology, biology, physics, 99(4), 884-894.
- Torgeson A, Lloyd S, Boothe D, Tao R, Whisenant J, Garrido-Laguna I, Cannon G (2017). Multiagent induction chemotherapy followed by chemoradiation is associated with improved survival in locally advanced pancreatic cancer. Cancer, 123(19), 3816-3824.
- Jairam V, Yu JB, Aneja S, Wilson LD, Lloyd (2017). Differences in Funding Sources of Phase III Oncology Clinical Trials by Treatment Modality and Cancer Type. American journal of clinical oncology, 40(3), 312-317.
- Lloyd S, Dosoretz AP, Yu JB, Evans SB, Decker RH (2016). Academic and Resident Radiation Oncologists' Attitudes and Intentions Regarding Radiation Therapy near the End of Life. Am J Clin Oncol, 39(1), 85-9.
- Orton A, Boothe D, Gan M, Monroe MM, Hitchcock YJ, Lloyd (2016). The "decay" of brachytherapy use in tumors of the oral cavity: A population-based patterns of care and outcomes analysis from 1973 to 2012. Brachytherapy, 15(6), 851-858.
- Odei BC, Boothe D, Lloyd S, Gaffney D (2016). A comprehensive analysis of brachytherapy clinical trials over the past 15 years. Brachytherapy, 15(6), 679-686.
- Davis BJ, Taira AV, Nguyen PL, Assimos DG, D'Amico AV, Gottschalk AR, Gustafson GS, Keole SR, Liauw SL, Lloyd S, McLaughlin PW, Movsas B, Prestidge BR, Showalter TN, Vapiwala (2016). ACR appropriateness criteria permanent source brachytherapy for prostate cancer.LID - S1538-4721(16)30558-X [pii]LID - 10.1016/j.brachy.2016.10.002 [doi]. Brachytherapy,
- Boothe D, Hopkins Z, Frandsen J, Lloyd (2016). Comparison of external beam radiation and brachytherapy to external beam radiation alone for unresectable extrahepatic cholangiocarcinoma. Journal of gastrointestinal oncology, 7(4), 580-7.
- Coffman A., Boothe D., Frandsen J, Lloyd (2016). Correlates and trends of IMRT use in locally advanced rectal cancer. doi:10.1007/s13566-016-0285-0. Journal of radiation oncology, 5(4), 427-35.
- Ganesan K, Lloyd S, Sarkar (2016). Discovering Related Clinical Concepts Using Large Amounts of Clinical Notes. Biomedical engineering and computational biology, 7(Suppl 2), 27-33.
- Husain ZA, Lloyd S, Shah C, Wilson LD, Koshy M, Mahmood (2015). Changes in brachytherapy-based APBI patient selection immediately before and after publication of the ASTRO consensus statement. Brachytherapy, 14(4), 490-5.
- Frandsen J, Boothe D, Gaffney DK, Wilson BD, Lloyd (2015). Increased risk of death due to heart disease after radiotherapy for esophageal cancer. Journal of gastrointestinal oncology, 6(5), 516-23.
- Lloyd S, Chung DH, Colaco RJ, Goodrich I, Cardinale F (2015). The Effect of Dose and Other Parameters on Outcomes in CyberKnife Stereotactic Radiosurgery for Trigeminal Neuralgia. Journal of radiation oncology, 4(4), 387-394.
- Gustafson GS, Nguyen PL, Assimos DG, D'Amico AV, Gottschalk AR, Hsu IC, Lloyd S, Mclaughlin PW, Merrick GS, Showalter TN, Taira AV, Vapiwala N, Yamada Y, Davis B (2014). ACR appropriateness Criteria(R) Postradical prostatectomy irradiation in prostate cancer. Oncology (Williston Park, N.Y.), 28(12), 1125-30, 1132-6.
- Lloyd S, Chang B (2014). Current strategies in chemoradiation for esophageal cancer. Journal of gastrointestinal oncology, 5(3), 156-65.
- Moran MS, Ma S, Jagsi R, Yang TJ, Higgins SA, Weidhaas JB, Wilson LD, Lloyd S, Peschel R, Gaudreau B, Rockwell (2013). A prospective, multicenter study of complementary/alternative medicine (CAM) utilization during definitive radiation for breast cancer. International journal of radiation oncology, biology, physics, 85(1), 40-6.
- Lloyd S, Chen Z, Foss FM, Girardi M, Wilson L (2013). Acute toxicity and risk of infection during total skin electron beam therapy for mycosis fungoides. Journal of the American Academy of Dermatology, 69(4), 537-43.
- Lloyd S, Buscariollo DL, Gross CP, Makarov DV, Yu J (2013). Determinants of enrollment in cancer clinical trials: the relationship between the current state of knowledge, societal disease burden, and randomized clinical trial enrollment. Journal of the National Comprehensive Cancer Network, 11(8), 928-36.
- Lloyd S, Chang B (2013). A comparison of three treatment strategies for locally advanced and borderline resectable pancreatic cancer. Journal of gastrointestinal oncology, 4(2), 123-30.
- Lloyd S, Chang B (2013). New possibilities and potential benefits for local control in locally recurrent pancreatic cancer. Journal of gastrointestinal oncology, 4(4), 340-2.
- Lloyd S, Decker RH, Evans S (2013). Bone scan findings of chest wall pain syndrome after stereotactic body radiation therapy: implications for the pathophysiology of the syndrome. Journal of thoracic disease, 5(2), E41-4.
- Lloyd S, Decker R (2013). Conference Scene: Notable Trial Results in Radiation Therapy for Lung Cancer at the ASCO Annual Meeting. Lung cancer management, 2(4), 271-4.
- Lloyd S, Yu JB, Wilson LD, Judson BL, Decker RH (2012). The prognostic importance of midline involvement in oral tongue cancer. Am J Clin Oncol, 35(5), 468-73.
- Yu JB, Lloyd S, Decker RH, Wilson LD, Park H (2012). Comparative Effectiveness Research and the Surveillance, Epidemiology, and End Results database: what is Comparative Effectiveness Research (CER) and why is it important?. Current problems in cancer, 36(4), 208-15.
- Park HS, Lloyd S, Decker RH, Wilson LD, Yu J (2012). Overview of the Surveillance, Epidemiology, and End Results database: evolution, data variables, and quality assurance. Current problems in cancer, 36(4), 183-90.
- Lloyd S, Park HS, Wilson LD, Decker RH, Yu J (2012). Prediction models, nomograms, and staging validation with the Surveillance, Epidemiology, and End Results database: using Surveillance, Epidemiology and End Results (SEER) program to create prediction models. Current problems in cancer, 36(4), 200-7.
- Park HS, Lloyd S, Decker RH, Wilson LD, Yu J (2012). Limitations and biases of the Surveillance, Epidemiology, and End Results database. Current problems in cancer, 36(4), 216-24.
- Lloyd S, Park HS, Decker RH, Wilson LD, Yu J (2012). Using the Surveillance, Epidemiology, and End Results database to investigate rare cancers, second malignancies, and trends in epidemiology, treatment, and outcomes. Current problems in cancer, 36(4), 191-9.
- Lloyd S, Yu JB, Wilson LD, Decker RH (2011). Determinants and patterns of survival in adenoid cystic carcinoma of the head and neck, including an analysis of adjuvant radiation therapy. Am J Clin Oncol, 34(1), 76-81.
- Lloyd S, Yu JB, Ross DA, Wilson LD, Decker R (2010). A prognostic index for predicting lymph node metastasis in minor salivary gland cancer. International journal of radiation oncology, biology, physics, 76(1), 169-75.
Review
- Zhao P, Jin R, Zhao B, Han L, Chen W, Hao N, Cui Y, Madan A, Awosika J, Lloyd S, Zhang (2024). The efficacy-associated biomarkers for immune checkpoint inhibitors in gastrointestinal cancer: a literature review. Journal of gastrointestinal oncology, 15(1), 514-528.
- Valle LF, Jiang T, Rosenbloom A, Zaorsky NG, Hwang C, Solanki A, Dickstein D, Mitin T, Schroeder T, Potters L, Lloyd S, Showalter T, Bagshaw HP, Jeffrey Karnes R, Hoffman KE, Nguyen PL, Kishan A (2024). American Radium Society Appropriate Use Criteria for the Workup and Treatment of Local Intraprostatic Recurrence of Prostate Cancer Following Definitive Radiotherapy. European urology oncology,
- Dinh TT, Mitin T, Bagshaw HP, Hoffman KE, Hwang C, Jeffrey Karnes R, Kishan AU, Liauw SL, Lloyd S, Potters L, Showalter TN, Taira AV, Vapiwala N, Zaorsky NG, D'Amico AV, Nguyen PL, Davis B (2021). Executive Summary of the American Radium Society Appropriate Use Criteria for Radiation Treatment of Node-Negative Muscle Invasive Bladder Cancer. International journal of radiation oncology, biology, physics, 109(4), 953-963.
- Torgeson A, Tao R, Garrido-Laguna I, Willen B, Dursteler A, Lloyd (2018). Large database utilization in health outcomes research in pancreatic cancer: an update. Journal of gastrointestinal oncology, 9(6), 996-1004.
Conference Proceedings
- Gan M, Boothe D, Neklason DW, Samadder NJ, Frandsen J, Keener MB, Lloyd (2016). Outcomes and Complications of Radiation Therapy in Patients with Familial Adenomatous Polyposis.
Editorial
- Lloyd (2018). Pancreas cancer, careful improvements and human connections. Journal of gastrointestinal oncology, 9(6), 979-981.
Other
- Ajani JA, D'Amico TA, Bentrem DJ, Corvera CU, Das P, Enzinger PC, Enzler T, Gerdes H, Gibson MK, Grierson P, Gupta G, Hofstetter WL, Ilson DH, Jalal S, Kim S, Kleinberg LR, Klempner S, Lacy J, Lee B, Licciardi F, Lloyd S, Ly QP, Matsukuma K, McNamara M, Merkow RP, Miller AM, Mukherjee S, Mulcahy MF, Perry KA, Pimiento JM, Reddi DM, Reznik S, Roses RE, Strong VE, Su S, Uboha N, Wainberg ZA, Willett CG, Woo Y, Yoon HH, McMillian NR, Stein (2025). Gastric Cancer, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology. Journal of the National Comprehensive Cancer Network, 23(5), 169-191.
He is very good at listening to the issues I had. Explains everything I could understand. Just a great person I wish I would not have had to meet him but was very pleasant at a difficult time in my live.
One terrific doc. Need I say more.
Very good doctor.
Dr Lloyd listens very well to your concerns and explains in simple terms any concerns that can be addressed.
A very good doctor
Dr Lloyd is very educated with different procedures within the US and with Europe he gives you options
Each of your associates did a good job bob.
Loved his demeanor
Dr Lloyd is a very personable and professional individual. I would thoroughly recommend him to anyone in need of his services.
Very good Dr
Dr Lloyd is very professional with a positive demeanor as well as a good listener.
Amazing, very knowledgeable and caring doctor. Highly recommended.
Dr loud is easy to talk to and seems to care about your concerns
Dr Loyd was courteous and straightforward which is what I like and took the time to listen to me
He was very kind very much to be able to understand. Everything explained. Everything showed everything on the screen and answered questions. Recommend him to anybody.
The weekly visits by Dr. Lloyd was very beneficial to me because I was to provide updates to my condition and he answered all questions/concerns I had.
Dr Lloyd was great. Very patient and even answered my silly questions
Dr. Loyd and his team took great care of main these stressful treatments. Listened with empathy and discussed care, as well as seemed to genuinely care about me. Thank you!
Dr. Lloyd is a very kind, compassionate person. Great customer service never rushes the appointment altogether always pleasant to see him.
Dr. Lloyd gave me tremendous confidence in my initial treatment for prostate cancer nearly 7 years ago. Since that time we have remained in contact, if only socially. Dr. Lloyd encouraged my latest series of psa tests which brought me to the point of exploring the potential for the return of cancer. Both he and his staff pressed me to return to Huntsman for additional testing which helped determine additional cancer had returned, if only in a small amount. Dr. Lloyd arranged additional radiation to resolve the cancer issue. The process has been relatively simple, easy and without concern. My confidence in Dr. Lloyd and his staff is beyond measure! Our advice to others entering the frightening world of cancer is to most definitely visit with Dr. Lloyd as the first step to a cure.
Careful, attentive, kind and thorough.
Not only is he an outstanding practioner, Dr. Lloyd is a very nice person.
Dr. Lloyd and his staff are the best. They are very caring, supportive, knowledgeable and informative. They helped me through a very difficult time and kept me going through the treatment. I can't thank them enough. I am very Greatful for Dr. Lloyd and his team.
Dr Lloyd took time to make eye contact with our child and to find common connections. He is extremely knowledgeable and willing to answer all of questions, explain treatment options and timing of treatment.
As always he is excellent and very thorough and thoughtful
Dr. Lloyd is a very professional individual. He explains things to patients and answers questions.
Excelente profesional
We immediately liked talking with Dr. Lloyd and he made us feel comfortable. He gave us important information which we appreciated. We are looking forward to getting this treatment and feel that it will be successful!!!
Dr.Lloyd is one excellent Doctor, I would recommend him to anyone
He is very caring.
A great doctor who cares about his patients, their well-being and health.
Thanks Dr. Lloyd, you made this journey way easier than I expected and the outcome was great. Really appreciate your kindness and your professionalism.
Dr Lloyd has always treated me with respect and listened to my questions and given me that answers that needed to be given. He has a very friendly bedside manner and makes me feel like I am the most important person in the room.
Great provider. Great person.
Wow he makes you feel so comfortable. He explains and listens to us.
Dr. Lloyd explained what to expect during the course of my treatment. He explained a clinical trial that I might want to take part in and it seemed like a good fit for me.
Dr. Lloyd was very descriptive & attentive. I liked his associates too, very well presented and felt very comfortable with asking questions.
Dr. Lloyd is a great provider. He is personable, knowledgable and thorough. Dr. Lloyd takes interest in the person not only as a patient, but also as a friend. On days that I have an office visit, Dr. Lloyd and his team make me feel as if I am their only patient for that day. I am fortunate to have Dr. Lloyd as one of my providers.
Excellent doctor. Avoid D. Hitchcock
Shane is amazing . You are in the best hands when you are with him , or any doctor with the U (Huntsman)
Dr. Lloyd listens, gives advice, and keeps a good sense of humor when needed. Perfect person for this field he is in.
He is confident, friendly, and very nice. it was a relaxed, informative visit.
The best. Very understanding. Listens to me. Very compassionate.
Dr. Lloyd is honest and upfront about treatment options and I appreciate his kind, compassionate demeanor. I feel as though he genuinely cares about me as a patient. He is considerate of my feelings and opinions and takes the time necessary to answer my questions and concerns.
r. Lloyd has treated me throughout my post operation radiation and I could not have felt better cared for. His focus, demeanor and expertise has made me feel completely comfortable with the process. Everything about his approach gives a feeling of incredible competence and caring.
Good experience.Very knowledgeable and compassionate.
Dr Lloyd seems to be very knowledgeable and direct to the point
He was very professional, knowledgeable, and explained things so I could understand. Very caring doctor.
Excellent
As I said before I'm comfortable with him and the plan he has for my treatment.
He listen to my concerns and gave expectations or resolve
Dr.Lloyd is the best in the field, I would recommend him to anyone
Very caring,
I have confidence in him and his skills to help!!!!
Great Doctor! Listens carefully to what you say. Professional, kind, considerate, great customer service!
El doctor es muy amable atento y siempre trata de aclarar todas mis dudas es buen doctor.
Good
Took the time to go over the options.
Very knowledgeable and polite to me and my wife.
Every staff member seems to have the patients best interests at heart and love their job
He is a great guy that cares about his patients. He has a calming way of talking to you and making you feel at ease.....
They were on time for our appointment, pleasant, great listener,shared concern for our decisions and that we understood what was happening and what was next possible procedures.
So good at explaining everything. He took his time with us. He made us feel at ease.
Dr Lloyd is an outstanding physician who provides excellent care. I am fortunate to be his patient.
Very positive. Dr. Lloyd put me at ease with explanation of care and including me in decision making.
Very professional, courteous and knowledgeable.
Phenomenal doctor. Takes all the time in the world answering questions and never in a rush. Always feel confident that I have received the best care possible.
Dr. Lloyd always listens carefully to all my concerns. He discusses options with me and helps me to get the care that I need. Dr. Lloyd is the best!
Personable, professional, courteous, etc.
pleasant, personable, calm, listens and responds appropriately.
Always listening. Never in a hurry. Couldn't be happier.
Dr Lloyd and his team took really good care of me during radiation treatments and after. I was impressed by the whole radiation team and their coordination. All the MDs, residents, nurses, techs, receptionists etc made treatment so much easier during a difficult time. I would highly recommend Dr. Lloyd.
Excellent experience. He always explains things so we can understand and is very good a giving us our options. He explains the direction we need to go and why. Very easy to talk to. Really appreciate all he does for me.
Dr Lloyd is very professional and caring at treats you like a person, not just a patient. His demeanor is soft yet thorough and he asks questions about your status.
not only a good doctor but is a good person
He was amazing
Care and concern
Dr. Lloyd did an excellent job of explaining my upcoming care. He was able to answer my questions and consider ideas and thoughts I had regarding my care.
Always pleasurable and remembers you and you uniqueness. Willing to explain all sides of the decision choices.
I've been seeing Dr Lloyd for two years. Superb Doc.
Dr. Lloyd has always been kind and respectful with me. Always letting me know what was happening in the exam at all times. I feel he is a wonderful Dr. I would recommend him to anyone with need for the services he provides, thank you Dr. Lloyd!
Took time to help me understand.
Good
Good
They have my highest recommendation. l
I don't make financial or medical recommendations.
I d not make financial or medical recommendations but my care was wonderful.
As I knew it would, this was an outstanding team at every level!
Great care provider
Very impressed with the thoroughness of the consultation.
Appointment was very professional and informative
Great doctor who explained plan for my treatment. He went over everything.
Dr Lloyd is incredible, trust him with my life, oh, I did that already
Concern for my care was excellent,
Listened and answered questions
Provider walked me through potential future treatments if needed
Shane Lloyd is excellent
Great
Took time to explain all procedures
We are seeking our radiology treatments with Dr. Binks in Rock Springs, WY which is where we live vs with Dr. Loyd in SLC.
I was happy to learn about the new Proton Therapy as another future option for my care.
Dr. Lloyd is one of the most easy-going, down to earth, truly caring doctors I've ever met and as long as he is there at Huntsman, I would have no reason to go anywhere else. One of his traits I really admire is that he is always willing to take whatever time is necessary to answer your questions.
good
dr. Lloyd was familiar with my diagnosis and tests that had been done. He was clear about what kind of radiation treatment he recommended and why. When I asked why another treatment was not preferred he explained clearly why it wasn't the best choice. I felt he cared about the difficulty of my prognosis and wanted to do the best for my care. I appreciated his help.
no one has talked to me about serviceability.
Dr. Lloyd was very interested and informative
Excellent Virtual appt. It would be difficult for me to be there. I live in N. Ogden
Dr. Lloyd is very personable and easy-going, explaining things in terms that anyone can understand. He instills confidence that your health is his primary concern and that they are doing everything that is needed to treat and address your concerns and condition.
good
attentive
Best care I could hope for always
The care providers here are the best!
very good
Great doctors and staff. gave info about cancer care. concerend for feelings of stress and his level of pain.Explained info and care.
This was a return checkup. Very little was discussed and no proposed treatment other than "come back in a year".
The after visit summaries in My Chart have been very helpful and appreciated.
All aspects thoroughly covered
Excellent manner and interview.
The video visit by the caregiver was an excellent experience.
Provider was prepared, showed genuine concern, and was attentive throughout the appointment.
great
buena
If I knew anyone with cancer I would the let them know about my experience at the Huntsman Cancer Institute.
Dr Lloyd could not be better. Hes excellent.